Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genaissance Pharmaceuticals (GNSC) -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (92)	4/29/2002 1:23:41 AM
From: mopgcw	Respond to of 183

Another seller: SOURCE: Form 144 ISSUER: GENAISSANCE PHARMACEUTICALS INC SYMBOL: GNSC FILER: MANTIS PARTNERS III LP TITLE: No Relation BROKER: MERRILL LYNCH & CO INC RESTRICTED SHARES TO SELL: 27,380 DATE REGISTERED: 04/25/02 APPROXIMATE DATE OF SALE: 03/14/02 The Form 144 is filed with the Securities and Exchange Commission to reflect the intention of any holder of restricted stock to sell those shares. After the 144 is mailed to the S.E.C., the filer is permitted to sell the shares, or any fraction of them, within 90 days. Form 144 data provided by: Washington Service (info@washserv.com)